COMPARISON OF O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE MESSENGER-RNA LEVELS IN HA-RAS MUTATED AND NON-MUTATED RAT MAMMARY-TUMORS INDUCED BYN-METHYL-N-NITROSOUREA
H. Inui et al., COMPARISON OF O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE MESSENGER-RNA LEVELS IN HA-RAS MUTATED AND NON-MUTATED RAT MAMMARY-TUMORS INDUCED BYN-METHYL-N-NITROSOUREA, Carcinogenesis, 15(3), 1994, pp. 459-463
Activation of the Ha-ras oncogene in N-methyl-N-nitrosourea (MNU))-ind
uced rat mammary tumors has been well documented. Such Ha-ras activati
on is thought to be brought about by direct action of carcinogens resu
lting in a G-->A transition at the second nucleotide of codon 12. Howe
ver, a DNA repair enzyme, O-6-methylguanine-DNA methyltransferase (MGM
T), can specifically remove methyl groups from O-6-methylguanine, whic
h is a major mutagenic and carcinogenic DNA lesion leading to the G-->
A transition. In this study, we compared the amount of MGMT mRNA in MN
U-induced rat mammary tumors with and without such Ha-ras activation.
A single injection of MNU into 82 female Sprague-Dawley rats induced 8
0 mammary carcinomas. RNase protection analysis and subsequent sequenc
ing revealed that 42 of 65 randomly selected tumors contained Ha-ras o
ncogenes activated by the G-->A transition. The amount of MGMT mRNA wa
s then measured by means of reverse transcriptase-mediated polymerase
chain reaction (RT-PCR) amplification and Southern hybridization. No o
bvious difference in the level of MGMT mRNA was detected between the t
wo tumor groups. In addition, in the course of our experiment, five of
42 tumors classified as containing activated Ha-ras oncogenes proved
to contain low percentages of tumor cells with the Ha-ras activation.
These results suggest that Haras activation in MNU-induced rat mammary
tumors may not necessarily be influenced by differences in MGMT activ
ity. They also raise the possibility that activation of other oncogene
s and/or inactivation of unidentified tumor suppressor gene(s) may be
involved in development of a certain proportion of tumors with activat
ed Ha-ras oncogenes, as is suspected in the case of tumors without Ha-
ras activation.